The present teachings provide various patient-specific augments used with implant components for the knee joint.
The present teachings provide a patient-specific augment that can be attached to an implant component for a bone of a joint of a patient. The patient-specific augment has first and second surfaces. The first surface is a three-dimensional patient-specific surface that closely matches and can mate to a substantially unaltered and unresected surface of a bone defect of the specific patient only in one position. The second surface is designed to engage a non-custom surface of the implant.
The augment can include a patient-specific peripheral surface between the first and second surfaces. The peripheral surface can have a patient-specific variable depth and/or a patient-specific variable radial dimension. In some embodiments, the augment can have a patient-specific step discontinuity in depth.
In some embodiments, the augment can be a femoral augment for a femoral knee component. In some embodiments, the augment can be a tibial augment for a tibial knee component. In some embodiments, the augment can be in the form of a sleeve with a generally tapered or cylindrical surface. In some embodiments, the augment can be generally block or plate-like.
The present teachings also include a method of preparing a knee joint for an implant component. The method includes preparing a bone end of the knee joint of the patient with standard resections configured to match a non-custom bone-engaging surface of an implant component without resecting a three-dimensional surface of a defect in the bone. A first implant-engaging surface of a patient-specific augment is attached to a portion of the bone-engaging surface of the implant. A second patient-specific three-dimensional surface of the augment is nestingly mated to the three-dimensional surface of the defect, and the implant is attached to the bone. According to the method, the patient-specific augment is designed during a preoperative plan for the specific patient. A three-dimensional image of the bone with the defect is reconstructed from a medical scan of the bone during a preoperative plan. An implant component is selected for the patient, and the patient-specific augment is manufactured from the three-dimensional image of the bone of the specific patient and the implant component.
Further areas of applicability of the present teachings will become apparent from the description provided hereinafter. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present teachings.
The present teachings will become more fully understood from the detailed description and the accompanying drawings, wherein:
The following description is merely exemplary in nature and is in no way intended to limit the present teachings, applications, or uses.
The present teachings generally provide various patient-specific augments for knee implants. The patient-specific augments are implants that can be used either with conventional femoral or tibial implant components. The patient-specific augments can be designed using computer-assisted image methods based on three-dimensional images of the patient's knee anatomy reconstructed from MRI, CT, ultrasound, X-ray or other three- or two-dimensional medical scans of the patient's anatomy. Various CAD programs and/or software can be utilized for three-dimensional image reconstruction, such as software commercially available, for example, by Materialise USA, Ann Arbor, Michigan.
According to the present teachings, the augments are customized to the anatomy of a specific patient to correct defects, irregularities and other deformities without having to sacrifice any additional amount of bone, as required by standard, non custom augments.
The patient-specific augments are generally formed using computer modeling based on the patient's three-dimensional (3-D) anatomic image and have an engagement surface that is made to conformingly contact and match a three-dimensional image of the patient's bone surface, by the computer methods discussed above. Various preoperative planning procedures and patient-specific instruments are disclosed in commonly assigned and co-pending U.S. patent application Ser. No. 11/756057, filed on May 31, 2007; U.S. patent application Ser. No. 12/211407, filed Sep. 16, 2008; U.S. patent application Ser. No. 11/971390, filed on Jan. 9, 2008, U.S. patent application Ser. No. 11/363548, filed on Feb. 27, 2006; and U.S. patent application Ser. No. 12/025414, filed Feb. 4, 2008. The disclosures of the above applications are incorporated herein by reference.
In the preoperative planning stage for a joint replacement or revision procedure, an MRI scan or a series of CT or other medical scans of the relevant anatomy of the patient, such as, for example, the bones (with or without articular cartilage) of the joint to be reconstructed, can be performed at a medical facility or doctor's office. The scan data obtained can be sent to a manufacturer. The scan data can be used to construct a three-dimensional image of the joint and provide an initial fitting in a computer file form or other computer representation.
The outcome of the initial fitting is an initial surgical plan that can be printed or provided in electronic form with corresponding viewing software. The initial surgical plan can be surgeon-specific, when using surgeon-specific alignment protocols. The initial surgical plan, in a computer file form associated with interactive software, can be sent to the surgeon, or other medical practitioner, for review. The surgeon can incrementally manipulate the position of images of the augment components and the implant components in an interactive image of the joint. Additionally, the surgeon can select or modify resection planes, types of augments, implants and orientations of augment and/or implant insertion. After the surgeon modifies and/or approves the surgical plan, the surgeon can send the final, approved plan to the manufacturer.
The present teachings provide patient-specific or custom implantable components or augments for use with femoral or tibial knee implants. Non-custom augments can be, for example, in the form of block augments, flat augments, conical, tapered and sleeve augments for the tibial and femoral implant components for augment corresponding areas of the patient's knee joint anatomy in connection with knee arthroplasty. The patient-specific augments of the present teachings have three-dimensional surfaces designed to closely conform to complementary bone surfaces of the patient's joint. Accordingly, the patient-specific augments of the present teachings deviate from the standard geometry of non-custom block, flat, conical, tapered and sleeve augments.
Each patient-specific augment generally includes a patient-specific surface mirroring and nestingly engaging a portion of the patient's anatomy and another surface that engages and mates to a corresponding (different) implant component in the manner of non custom augments. In this respect, the patient-specific augment can be designed for a particular patient to correct a defect while minimizing sacrificed bone and yet be used with an off-the-shelf non-custom implant component of a size appropriate for the patient.
Referring to
Referring to
Referring to
As an example of the procedure used with prior art, non-custom augments,
The various augments can be made of biocompatible materials, including metals, titanium alloys, porous metals or other material with porous coatings for bone in-growth, including, for example, porous titanium, such as Regerenex, commercially available from Biomet Manufacturing Corp, Warsaw, Ind.
More specifically,
The femoral augment 100 has a bone-engaging surface 104 generally opposite to an implant-engaging surface 102 and a three-dimensional peripheral bone-engaging surface 106. In this respect, the femoral augment 100 can be bounded by opposing surfaces 104, 102 and peripheral surface 106 that joins the opposing surfaces 102, 104. The femoral augment 100 can include a fixation aperture 107 for a fixation member 110, such as a fastener or set screw for coupling the femoral augment 100 to the femoral implant 30c. The femoral augment can also be cemented to the femoral implant 30c. The bone-engaging surface 104 is a patient-specific surface designed according to the preoperative plan for the patient based on a three-dimensional reconstructed image of the patient's anatomy, including a substantially unaltered and unresected surface of a bone defect of the patient, using medical scans, as discussed above. The patient-specific surface 104 is generally a curved three-dimensional surface designed to closely and nestingly mate in mirror-image fashion with a complementary surface of the specific patient's bone, including any defects, asymmetries or other irregularities for correcting such irregularities. For example, the bone-engaging surface 104 of the femoral augment 100 can include convex, concave, planar or other portions with generally continuous or piece-wise variable geometry and/or curvature. The peripheral surface 106, to the extent that it engages the patient's anatomy, can also be designed to be patient-specific or have patient-specific portions based on the preoperative plan. The thickness or depth h of the augment 100 is patient-specific and can also be variable or non-uniform, as shown in
Referring to
Referring to
Referring the
Referring to
The present teachings generally provide various augments to be used with different implant components for a joint, such as the knee. Each of the augments of the present teachings are patient-specific and are designed for the anatomic features, including a substantially unaltered and unresected surface of a bone defect of a specific patient, based on a preoperative plan for the patient in which a three-dimensional computer image of the patient's joint is constructed. Using patient-specific augments that closely conform to the patient's geometry helps correct defects and other irregularities with reduced or minimal bone removed, while non-custom joint implants and other joint replacement components can fit as planned for the specific patient. In this respect, the augments of the present teachings can be used with non-custom implants, such as non-custom femoral and tibial knee implants. It is contemplated, however that the augments of the present teachings can also be used with implants having patient-specific geometries in areas other than those engaging the augment. For example, the femoral implant 30 can be designed with an outer surface 38 that is patient-specific and matches, for example, the anatomy of a healthy articular surface of the femur of the patient.
The various augments can be attached to the corresponding implants with cement, screws, bolts, set screws or other fasteners, or received in counter recesses of the implant or secured with a taper fit connection (taper to taper) in corresponding bores of the implant, as discussed above.
The foregoing discussion discloses and describes merely exemplary arrangements of the present teachings. Furthermore, the mixing and matching of features, elements and/or functions between various embodiments is expressly contemplated herein, so that one of ordinary skill in the art would appreciate from this disclosure that features, elements and/or functions of one embodiment may be incorporated into another embodiment as appropriate, unless described otherwise above. Moreover, many modifications may be made to adapt a particular situation or material to the present teachings without departing from the essential scope thereof. One skilled in the art will readily recognize from such discussion, and from the accompanying drawings and claims, that various changes, modifications and variations can be made therein without departing from the spirit and scope of the present teachings as defined in the following claims.
This application claims the benefit of U.S. Provisional Application No. 61/446,660, filed on Feb. 25, 2011. This application is a continuation-in-part of U.S. application Ser. Nos. 13,041,469, 13/041,495, 13/041,665 and 13/041,883, each filed on Mar. 7, 2011, each of which is a continuation-in-part of U.S. application Ser. No. 12/978,069 filed Dec. 23, 2010, which is a continuation-in-part of U.S. application Ser. No. 12/973,214, filed Dec. 20, 2010, which is a continuation-in-part of U.S. application Ser. No. 12/955,361 filed Nov. 29, 2010, which a continuation-in-part of U.S. application Ser. Nos. 12/938,905 and 12/938,913, both filed Nov. 3, 2010, each of which is a continuation-in-part of U.S. application Ser. No. 12/893,306, filed Sep. 29, 2010, which is a continuation-in-part of U.S. application Ser. No. 12/888,005, filed Sep. 22, 2010, which is a continuation-in-part of U.S. application Ser. No. 12/714,023, filed Feb. 26, 2010, which is a continuation-in-part of U.S. application Ser. No. 12/571,969, filed Oct. 1, 2009, which is a continuation-in-part of U.S. application Ser. No. 12/486,992, filed Jun. 18, 2009, and is a continuation-in-part of U.S. application Ser. No. 12/389,901, filed Feb. 20, 2009, which is a continuation-in-part of U.S. application Ser. No. 12/211,407, filed Sep. 16, 2008, which is a continuation-in-part of U.S. application Ser. No. 12/039,849, filed Feb. 29, 2008, which: (1) claims the benefit of U.S. Provisional Application No. 60/953,620, filed on Aug. 2, 2007, U.S. Provisional Application No. 60/947,813, filed on Jul. 3, 2007, U.S. Provisional Application No. 60/911,297, filed on Apr. 12, 2007, and U.S. Provisional Application No. 60/892,349, filed on Mar. 1, 2007; (2) is a continuation-in-part U.S. application Ser. No. 11/756,057, filed on May 31, 2007, which claims the benefit of U.S. Provisional Application No. 60/812,694, filed on Jun. 9, 2006; (3) is a continuation-in-part of U.S. application Ser. No. 11/971,390, filed on Jan. 9, 2008, which is a continuation-in-part of U.S. application Ser. No. 11/363,548, filed on Feb. 27, 2006; and (4) is a continuation-in-part of U.S. application Ser. No. 12/025,414, filed on Feb. 4, 2008, which claims the benefit of U.S. Provisional Application No. 60/953,637, filed on Aug. 2, 2007. This application is continuation-in-part of U.S. application Ser. No. 12/872,663, filed on Aug. 31, 2010, which claims the benefit of U.S. Provisional Application No. 61/310,752 filed on Mar. 5, 2010. This application is a continuation-in-part of U.S. application Ser. No. 12/483,807, filed on Jun. 12, 2009, which is a continuation-in-part of U.S. application Ser. No. 12/371,096, filed on Feb. 13, 2009, which is a continuation-in-part of U.S. application Ser. No. 12/103,824, filed on Apr. 16, 2008, which claims the benefit of U.S. Provisional Application No. 60/912,178, filed on Apr. 17, 2007. This application is also a continuation-in-part of U.S. application Ser. No. 12/103,834, filed on Apr. 16, 2008, which claims the benefit of U.S. Provisional Application No. 60/912,178, filed on Apr. 17, 2007. The disclosures of the above applications are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
Parent | 13047924 | Mar 2011 | US |
Child | 14812583 | US |